Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study
Articolo
Data di Pubblicazione:
2007
Abstract:
Helicobacter pylori eradication rate following standard triple therapy is decreasing worldwide. A quadruple therapy with lactoferrin and a levofloxacin-based triple therapy has been found to achieve a very high (>90%) cure rate. This study aimed to confirm these encouraging results.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy; Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Ofloxacin; Tinidazole; Treatment Outcome
Elenco autori:
Zullo, A; De Francesco, V; Scaccianoce, G; Manes, G; Efrati, C; Hassan, Cesare; Maconi, G; Piglionica, D; Cannaviello, C; Panella, C; Morini, S; Ierardi, E.
Link alla scheda completa:
Pubblicato in: